Wendy A. Cyr
Publications by Year
Research Areas
RNA Research and Splicing, RNA modifications and cancer, RNA Interference and Gene Delivery, MicroRNA in disease regulation, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1(2016)82 cited
- → Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin(2016)61 cited
- → Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo(2013)57 cited
- → β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models(2017)21 cited
- → Abstract B20: EnCore-LNP mediated tumor delivery of MYC and CTNNB1 Dicer Substrate RNAs (DsiRNAs)(2015)3 cited
- → Abstract 3827: Preclinical characterization of DCR-BCAT as a component of combination therapy(2016)1 cited
- → Abstract B222: Dicer substrate siRNAs to MYC, B-catenin, and other target genes effectively induce in vivo target gene knockdown and tumor inhibition.(2013)1 cited
- → GalXC technology enables potent and durable RNAi-mediated inhibition of hepatitis B virus in preclinical models(2018)1 cited
- → Abstract 3533: Systemic delivery of CTNNB1 Dicer-substrate siRNAs (DsiRNAs) leads to efficient oncogene silencing in diverse tumor types of extra hepatic origin(2015)1 cited
- → Supplemental figures S1-9 from Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin(2023)